Accession Number: | 0001225208-23-001356 |
Date: | 2023-02-03 |
Issuer: | BOSTON SCIENTIFIC CORP (BSX) |
Original Submission Date: |
BUTCHER ARTHUR C
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-02-03 | M | 10,822 | a | $16.31 | 46,180 | direct | ||
COMMON STOCK | 2023-02-03 | M | 4,212 | a | $17.26 | 50,392 | direct | ||
COMMON STOCK | 2023-02-03 | S | 27,000 | d | $48.74 | 23,392 | direct | ||
COMMON STOCK | 2023-02-03 | 0 | $0.00 | 2,545 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 17.26 | 2023-02-03 | deemed execution date | M | 4,212 (d) | 2026-02-22 | common stock 4,212 | $17.26 | 11,931 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 16.31 | 2023-02-03 | deemed execution date | M | 10,822 (d) | 2025-02-23 | common stock 10,822 | $16.31 | 0 | direct |
ID | footnote |
---|---|
f1 | represents the weighted average sale price. these shares were sold in multiple transactions at prices ranging from $48.70 to $48.78, inclusive. the reporting person undertakes to provide upon request by the u.s. securities and exchange commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
f2 | balance reflects the most current data available with regard to share holdings in the company's 401(k) retirement savings plan. |
f3 | grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on february 22, 2017, the first anniversary of the date of grant. |
f4 | grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on february 23, 2016, the first anniversary of the date of grant. |